(Q50545451)
Statements
1 reference
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark. (English)
1 reference
Hansen OP
1 reference
Pedersen-Bjergaard J
1 reference
Ellegaard J
1 reference
Brincker H
1 reference
Boesen AM
1 reference
Christensen BE
1 reference
Drivsholm A
1 reference
Hippe E
1 reference
Jans H
1 reference
Jensen KB
1 reference
1 June 1991
1 reference
1 reference
5
1 reference
6
1 reference
510-516
1 reference
Identifiers
1 reference